image: Injection of an antibody treatment durably reversed depigmentation in mice with vitiligo, as evidenced by the darkening of the tail (right), compared to control mice with vitiligo (left). This material relates to a paper that appeared in the 18 July, issue of Science Translational Medicine, published by AAAS. The paper, by J.M. Richmond at University of Massachusetts Medical School in Worcester, MA; and colleagues was titled, "Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo." view more
Credit: J.M. Richmond <i>et al., Science Translational Medicine </i>(2018)